Successful Anti‐TNFα Treatment in a Child with Posttransplant Recurrent Focal Segmental Glomerulosclerosis
暂无分享,去创建一个
S. Leroy | G. Deschênes | A. Bensman | V. Guigonis | S. Leroy | T. Ulinski | V. Emal-Aglaé | D. Bruckner
[1] L. Tomlinson,et al. Granulomatous interstitial nephritis treated with a tumour necrosis factor-α inhibitor , 2006 .
[2] M. Pescovitz,et al. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. , 2006, The New England journal of medicine.
[3] L. Tomlinson,et al. Granulomatous interstitial nephritis treated with a tumour necrosis factor-alpha inhibitor. , 2006, Nephrology, Dialysis and Transplantation.
[4] G. Ciancio,et al. Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience , 2005, Pediatric Nephrology.
[5] D. Raveh,et al. Tumor necrosis factor-α blocking agent as a treatment for nephrotic syndrome , 2004, Pediatric Nephrology.
[6] J. G. van den Berg,et al. Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. , 2004, Clinical science.
[7] L. Travis,et al. High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] D. Raveh,et al. Tumor necrosis factor-alpha blocking agent as a treatment for nephrotic syndrome. , 2004, Pediatric nephrology.
[9] A. Bakr,et al. Tumor necrosis factor-α production from mononuclear cells in nephrotic syndrome , 2003, Pediatric Nephrology.
[10] E. Lerut,et al. Benefit of anti-TNF a treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis , 2003 .
[11] A. Bakr,et al. Tumor necrosis factor-alpha production from mononuclear cells in nephrotic syndrome. , 2003, Pediatric nephrology.
[12] R. Busund,et al. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial , 2002, Intensive Care Medicine.
[13] E. Drewe,et al. Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome. , 2000, The New England journal of medicine.
[14] S. Kim,et al. Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] V. Savin,et al. TNF-alpha increases albumin permeability of isolated rat glomeruli through the generation of superoxide. , 1998, Journal of the American Society of Nephrology : JASN.
[16] H. Ha,et al. Role of tumor necrosis factor-alpha on mesangial cell MCP-1 expression and monocyte migration: mechanisms mediated by signal transduction. , 1996, Journal of the American Society of Nephrology : JASN.
[17] V. Savin,et al. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] B. Myers,et al. Elevated Levels of Tumor Necrosis Factor-α in the Nephrotic Syndrome in Humans , 1993 .
[19] B. Myers,et al. Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] J. Cameron,et al. Recurrence of focal segmental glomerulosclerosis in renal allografts. , 1981, Transplantation.